Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-599-9 | CAS number: 7647-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Test method equivalent or similar to OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity in Rodents).
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 983
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- (The number of animals included in the study is not specified; clinical chemistry and ophtalmoscopic examinations were not performed).
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Sodium bromide
- EC Number:
- 231-599-9
- EC Name:
- Sodium bromide
- Cas Number:
- 7647-15-6
- Molecular formula:
- BrNa
- IUPAC Name:
- Active bromine generated from sodium bromide and sodium hypochlorite
- Details on test material:
- - Name of test material (as cited in study report): sodium bromide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- unchanged (no vehicle)
- Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- 90 days.
- Frequency of treatment:
- Daily.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
75, 300, 1200, 4800, 19200 mg/kg diet.
Basis:
nominal in diet
- No. of animals per sex per dose:
- No data.
- Positive control:
- None
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
DETAILED CLINICAL OBSERVATIONS: Yes
BODY WEIGHT: Yes.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes.
HAEMATOLOGY: Yes. - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes (organs examined: musculature, thyroid, prostate and adrenals).
HISTOPATHOLOGY: Yes (organs examined: musculature, thyroid, prostate and adrenals). - Statistics:
- No data.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- (in the 19,200 mg/kg diet group)
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- (in the 19,200 mg/kg diet group)
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- (in the 19,200 mg/kg diet group)
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- (in the 19,200 mg/kg diet group)
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- (in the 19,200 mg/kg diet group)
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- (in females exposed to ≥1200 mg/kg and in males exposed to ≥4800 mg/kg)
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- (in the highest dosage groups)
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- CLINICAL SIGNS AND MORTALITY
Depressed grooming and motor incoordination of the hind legs were observed at the highest dose level. These effects may have been due to a disturbance of the central nervous system by bromide.
BODY WEIGHT AND WEIGHT GAIN
A significant growth retardation was observed in both sexes fed 19,200 mg/kg diet.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
The highest dosage group (19,200 mg/kg diet) showed a slight decrease in food conversion.
HAEMATOLOGY
A slight decrease in the concentration of lymphocytes and a doubling in the concentration of neutrophilic granulocytes were found in both sexes of the 19,200 mg/kg diet group. The increase in neutrophilic granulocytes may be regarded as a stress-mediated effect, although it cannot be excluded that the effect was originated from a bacterial infection as a result of the bad physical condition of the animals. The effect on the lymphocytes may be suggestive of a slight suppressive effect on the immune system by bromide.
ORGAN WEIGHTS
The most prominent effects were on the thyroid and the gonads. The relative weight of the thyroid was increased in females from exposed to ≥1200 mg sodium bromide/kg diet and in males at the highest dose level (19,200 mg/kg diet). Males exposed to 4800 and 19200 mg/kg diet showed a decrease in the relative prostate weight.
HISTOPATHOLOGY: NON-NEOPLASTIC
A complex of histopathological changes was observed in the endocrine system. A no-effect level of 300 mg/kg diet was established on the basis of the effects on the thyroid. A remarkable thyroid activation was found for both sexes in the highest dose group. In addition, a decrease in spermatogenesis and a decrease in vacuolization of the zona fasciculata in the adrenals were observed in males. Furthermore, females showed a decrease in the number of corpora lutea.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 300 mg/kg diet
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: (equivalent to 30 mg/kg bw/day for young rats and 15 mg/kg bw/day for older rats). Based on thyroid effects.
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Effect levels:
The effect levels were reported as Concentration of the substance in feed (mg/kg diet). In order to express the dose levels as mg/kg Body Weight Per Day, a conversion factor of 0.1 for young rats and 0.05 for older rats were used (in accordance with the OECD Environment, Health and Safety Publications Series on Testing and Assessment No.51, Paris, 2006).
Applicant's summary and conclusion
- Conclusions:
- The NOAEL after 90 days oral exposure to sodium bromide was determined to be 300 mg/kg diet (equivalent to 30 mg/kg bw/day for young rats and 15 mg/kg bw/day for older rats), on the basis of the effects on the thyroid.
- Executive summary:
A subchronic oral toxicity study was performed with sodium bromide following a method equivalent or similar to OECD Guideline 408. Wistar male and female rats were exposed to the test substance at dietary concentrations of 75, 300, 1200, 4800 and 19,200 mg sodium bromide/kg diet in a 90 -day test. Clinical observations, body weight and food consumption determinations, as well as haematological examinations were performed throughout the test. At the end of the study gross pathology and histopathology examinations were performed in the musculature, the thyroid, the prostate and the adrenal glands. Depressed grooming and motor incoordination of the hind legs were observed only in the highest dose level. These effects may had been due to a disturbance of the central nervous system by bromide levels. A significant growth retardation was also observed in both sexes in the 19,200 mg/kg diet dosage group, along with a slight decrease in food conversion. In the haematologic evaluation performed, a slight decrease in the concentration of lymphocytes and a doubling in the concentration of neutrophilic granulocytes were found in both sexes. The most prominent effects were on the thyroid and the gonads. The relative weight of the thyroid was increased in females exposed to ≥1200 mg sodium bromide/kg diet and in males at the highest dose level (19,200 mg/kg diet). Males exposed to 4800 and 19,200 mg/kg diet showed a decrease in the relative prostate weight. These changes were confirmed by the observation of a complex of histopathological changes in the endocrine system. A remarkable thyroid activation was found for both sexes in the highest dose group. In addition, a decrease in the spermatogenesis and a decrease in the vacuolization of the zona fasciculata in the adrenals were observed in males. Furthermore, females showed a decrease in the number of corpora lutea. The NOAEL after 90 days oral exposure to sodium bromide was determined to be 300 mg/kg diet (equivalent to 30 mg/kg bw/day for young rats and 15 mg/kg bw/day for older rats), on the basis of the effects on the thyroid.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.